{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "FUM.L",
  "generated_at": "2026-01-21T22:43:07.643479Z",
  "top_card": {
    "ticker": "FUM.L",
    "company_name": "Futura Medical plc",
    "sector": "Healthcare",
    "market_cap_gbp": 6842227,
    "days_active": 42,
    "apex_score_100": 50,
    "confidence_score_100": 60,
    "ai_final_score_25": 11,
    "ai_strength": "MODERATE",
    "timing_regime": "CONFIRMED",
    "action": "HOLD/WATCH",
    "thesis_one_liner": "HOLD/WATCH - CONFIRMED timing with 50/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Futura Medical plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 6842227,
      "current_close_price": 1.2425
    },
    "basics": {
      "ticker": "FUM.L",
      "current_price": 1.2425,
      "ath": 84.0,
      "atl": 0.989,
      "ath_date": "2021-03-22",
      "atl_date": "2025-12-03",
      "week_52_high": 32.5,
      "week_52_low": 0.989,
      "week_52_high_date": "2025-01-21",
      "week_52_low_date": "2025-12-03",
      "drawdown_from_ath_pct": 98.52,
      "data_start": "2020-01-02",
      "data_end": "2026-01-21",
      "total_bars": 1529
    },
    "latest_signal": {
      "date": "2025-12-10",
      "scan_date": "2026-01-14",
      "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
      "signal_color": "PURPLE",
      "price": 1.08,
      "drawdown_pct": 96.82,
      "ai_score": 9.0,
      "rsi": 39.8,
      "cycle_position": 0.0319,
      "holding_period_days": 42,
      "current_pnl_pct": 15.05,
      "rally_state": "rallying",
      "distance_from_high_pct": -19.84,
      "Rally_Count": 1,
      "days_since_last_high": 9,
      "last_high_date": "2026-01-12",
      "lock_in_reached": true,
      "lock_in_date": "2026-01-12",
      "best_rally_pct": 43.52
    },
    "best_historical_signal": {
      "signal_date": "2025-07-02",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "entry_price": 7.45,
      "peak_price": 15.0,
      "peak_date": "2025-07-11",
      "rally_pct": 101.34,
      "days_to_peak": 9,
      "ai_score": 9.0
    },
    "all_historical_signals": [
      {
        "signal_id": "FUM.L_2025-05-21",
        "signal_date": "2025-05-21",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 8.0,
        "current_price": 1.3593,
        "current_return_pct": -83.01,
        "best_rally_pct": 67.81,
        "best_rally_date": "2025-07-25",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -89.87,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 238,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-06-27",
        "signal_date": "2025-06-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.6,
        "current_price": 1.3593,
        "current_return_pct": -82.11,
        "best_rally_pct": 76.64,
        "best_rally_date": "2025-07-25",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -89.87,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 201,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-07-02",
        "signal_date": "2025-07-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.45,
        "current_price": 1.3593,
        "current_return_pct": -81.75,
        "best_rally_pct": 80.2,
        "best_rally_date": "2025-07-25",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -89.87,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 196,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-07-03",
        "signal_date": "2025-07-03",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.45,
        "current_price": 1.3593,
        "current_return_pct": -81.75,
        "best_rally_pct": 80.2,
        "best_rally_date": "2025-07-25",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -89.87,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 195,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-19",
        "signal_date": "2025-09-19",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 5.245,
        "current_price": 1.3593,
        "current_return_pct": -74.08,
        "best_rally_pct": -5.62,
        "best_rally_date": "2025-09-22",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 117,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-22",
        "signal_date": "2025-09-22",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 4.95,
        "current_price": 1.3593,
        "current_return_pct": -72.54,
        "best_rally_pct": -17.07,
        "best_rally_date": "2025-09-23",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 114,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-23",
        "signal_date": "2025-09-23",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 4.105,
        "current_price": 1.3593,
        "current_return_pct": -66.89,
        "best_rally_pct": -4.99,
        "best_rally_date": "2025-09-24",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 113,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-24",
        "signal_date": "2025-09-24",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 3.9,
        "current_price": 1.3593,
        "current_return_pct": -65.15,
        "best_rally_pct": -0.9,
        "best_rally_date": "2025-09-25",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 112,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-25",
        "signal_date": "2025-09-25",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 3.865,
        "current_price": 1.3593,
        "current_return_pct": -64.83,
        "best_rally_pct": -0.52,
        "best_rally_date": "2025-09-29",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 111,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-26",
        "signal_date": "2025-09-26",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 3.29,
        "current_price": 1.3593,
        "current_return_pct": -58.68,
        "best_rally_pct": 16.87,
        "best_rally_date": "2025-09-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -64.65,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 110,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-09-29",
        "signal_date": "2025-09-29",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 3.845,
        "current_price": 1.3593,
        "current_return_pct": -64.65,
        "best_rally_pct": -1.17,
        "best_rally_date": "2025-09-30",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 107,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-10-07",
        "signal_date": "2025-10-07",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 2.345,
        "current_price": 1.3593,
        "current_return_pct": -42.03,
        "best_rally_pct": 27.08,
        "best_rally_date": "2025-10-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -54.39,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 99,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-10-13",
        "signal_date": "2025-10-13",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 2.0,
        "current_price": 1.3593,
        "current_return_pct": -32.03,
        "best_rally_pct": 49.0,
        "best_rally_date": "2025-10-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -54.39,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 93,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-10-14",
        "signal_date": "2025-10-14",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 2.01,
        "current_price": 1.3593,
        "current_return_pct": -32.37,
        "best_rally_pct": 48.26,
        "best_rally_date": "2025-10-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -54.39,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 92,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-11-13",
        "signal_date": "2025-11-13",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.58,
        "current_price": 1.3593,
        "current_return_pct": -13.97,
        "best_rally_pct": -1.9,
        "best_rally_date": "2026-01-12",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 62,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-11-14",
        "signal_date": "2025-11-14",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 1.3,
        "current_price": 1.3593,
        "current_return_pct": 4.56,
        "best_rally_pct": 19.23,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.3,
        "days_since_last_high": 28,
        "lock_in_reached": true,
        "age_days": 61,
        "status": "historical"
      },
      {
        "signal_id": "FUM.L_2025-11-17",
        "signal_date": "2025-11-17",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.283,
        "current_price": 1.35,
        "current_return_pct": 5.22,
        "best_rally_pct": 20.81,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -12.9,
        "days_since_last_high": 29,
        "lock_in_reached": true,
        "age_days": 59,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-11-20",
        "signal_date": "2025-11-20",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.195,
        "current_price": 1.3175,
        "current_return_pct": 10.25,
        "best_rally_pct": 29.71,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -15.0,
        "days_since_last_high": 31,
        "lock_in_reached": true,
        "age_days": 58,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-11-21",
        "signal_date": "2025-11-21",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.19,
        "current_price": 1.2625,
        "current_return_pct": 6.09,
        "best_rally_pct": 30.25,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -18.55,
        "days_since_last_high": 7,
        "lock_in_reached": true,
        "age_days": 59,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-11-27",
        "signal_date": "2025-11-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.14,
        "current_price": 1.2425,
        "current_return_pct": 8.99,
        "best_rally_pct": 35.96,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 2,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 55,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-12-03",
        "signal_date": "2025-12-03",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 1.055,
        "current_price": 1.2425,
        "current_return_pct": 17.77,
        "best_rally_pct": 46.92,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 49,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-12-04",
        "signal_date": "2025-12-04",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.085,
        "current_price": 1.2425,
        "current_return_pct": 14.52,
        "best_rally_pct": 42.86,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 2,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 48,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-12-05",
        "signal_date": "2025-12-05",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.02,
        "current_price": 1.2425,
        "current_return_pct": 21.81,
        "best_rally_pct": 51.96,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 47,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-12-09",
        "signal_date": "2025-12-09",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.13,
        "current_price": 1.2425,
        "current_return_pct": 9.96,
        "best_rally_pct": 37.17,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 2,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 43,
        "status": "active"
      },
      {
        "signal_id": "FUM.L_2025-12-10",
        "signal_date": "2025-12-10",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.08,
        "current_price": 1.2425,
        "current_return_pct": 15.05,
        "best_rally_pct": 43.52,
        "best_rally_date": "2026-01-12",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -19.84,
        "days_since_last_high": 9,
        "lock_in_reached": true,
        "age_days": 42,
        "status": "active"
      }
    ],
    "stats": {
      "total_signals": 25,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 47.8,
      "median_rally_pct": 47.06,
      "best_rally_pct": 101.34,
      "worst_rally_pct": 4.03
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-21 22:06:15 UTC",
    "volatility": {
      "atr_normalized": 6.02,
      "stddev_20d": 0.3466
    },
    "trends": {
      "intelligence_signal": "UPTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 50/100 indicates strong opportunity quality",
      "Timing regime: CONFIRMED",
      "Historical profile: 1 rallies, 44% best run"
    ],
    "main_risk": "Confidence 60/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "FUM.L",
      "latest": [
        {
          "title": "Holding(s) in Company",
          "announcement_date": "13th Jan 2026",
          "release_time": "12:53 pm",
          "source": "RNS",
          "content": "13 Jan 2026 12:53\nRNS Number : 7389O\nFutura Medical PLC\n13 January 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nFutura Medical PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nLombard Odier Asset Management (Europe) Limited\nCity and country of registered office (if applicable)\nLondon, United Kingdom\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nDisclosure on behalf of accounts managed on a discretionary basis by Lombard Odier Investment Managers group\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n12.01.2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n13.01.2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n10.96%\n10.96%\n63,734,748\nPosition of previous notification (if\napplicable)\n11.87%\n11.87%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB0033278473\n63,734,748\n10.96%\nSUBTOTAL 8. A\n63,734,748\n10.96%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon, United Kingdom\nDate of completion\n13.01.2026\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLEAAFDFSAKEFA",
          "rns_number": "RNS Number : 7389O"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "13th Jan 2026",
          "release_time": "12:51 pm",
          "source": "RNS",
          "content": "13 Jan 2026 12:51\nRNS Number : 7386O\nFutura Medical PLC\n13 January 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nFutura Medical PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nLombard Odier Asset Management (Europe) Limited\nCity and country of registered office (if applicable)\nLondon, United Kingdom\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nDisclosure on behalf of accounts managed on a discretionary basis by Lombard Odier Investment Managers group\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n09.01.2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n12.01.2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n11.87%\n11.87%\n69,034,748\nPosition of previous notification (if\napplicable)\n12.76%\n12.76%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB0033278473\n69,034,748\n11.87%\nSUBTOTAL 8. A\n69,034,748\n11.87%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon, United Kingdom\nDate of completion\n12.01.2026\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLEAAFDFLNKEFA",
          "rns_number": "RNS Number : 7386O"
        },
        {
          "title": "Results of WSD4000 Early Feasibility Study",
          "announcement_date": "12th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "12 Jan 2026 07:00\nRNS Number : 4887O\nFutura Medical PLC\n12 January 2026\n12 January 2026\nFutura Medical plc\n(\"Futura\", \"the Group\" or the \"Company\")\nPositive results from WSD4000 Early Feasibility Study\nHighly statistically significant improvement achieved in female sexual function\nFutura Medical (AIM: FUM), the consumer healthcare Group behind Eroxon\u00ae that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, is pleased to report positive results of the WSD4000 Early Feasibility Study ('EFS') which comprised of 12 women suffering from some degree of sexual dysfunction.\nThe positive trends and high response metrics demonstrate that the product has the potential to deliver a significant improvement in impaired sexual function in women. Given the lack of known regulatory-approved OTC treatment available for this condition in women, this represents a significant opportunity for WSD4000 globally.\nEFS results\nWhilst the size of the EFS study was relatively modest, the results are highly encouraging and give the Company confidence to proceed to the next steps of designing a Phase 3 clinical study which will be further informed by a small in-clinic sham / placebo controlled sensory study (results expected in mid 2026), and a 200 subject home user study (results expected in mid 2026).\n\u00b7\nUsing the internationally recognised Total Female Sexual Function Index ('FSFI') scale, a highly statistically significant improvement over baseline was achieved in overall sexual function\n\u00b7\nOn average, an improvement in overall sexual function of 6.35 units over baseline (pre-treatment) in the FSFI scale was achieved which exceeded the minimal clinically important difference of 4 units defined by expert scientific consensus\n\u00b7\nStatistically significant improvements were achieved in five of the six FSFI domains: sexual arousal, lubrication, pain improvement, ability to orgasm and sexual satisfaction\n\u00b7\nJudged to be effective in both pre- and post-menopausal women\n\u00b7\nUsing the Female Sexual Encounter Profile ('FSEP') metrics, meaningful improvements were achieved in all measures across the 56 sexual encounters recorded:\no\n64.2% of uses were described as experiencing moderate or high desire\no\n83.9% of uses reported satisfaction with arousal\no\n71.4% of uses reported enough lubrication for comfortable intercourse\no\n69.6% of uses resulted in orgasm\no\n78.6% of uses reported moderate or high arousal\no\n91.1% reported conditions appropriate for a satisfactory sexual encounter\n\u00b7\nEvery use of the gel (56 in total) resulted in a genital sensation which occurred on average in less than five minutes in 9 out of 10 uses\n\u00b7\nThe product was well tolerated. 58% subjects experienced a mild to moderate but transient \"burning\" sensation which in general led to higher efficacy levels indicating that subjects regarded this as a sensory signal that \"the product was working\". No subjects discontinued use of the product.\nAbout the EFS\nThe EFS of the WSD4000 prototype followed the Food and Drug Administration's ('FDA') guidance from a recent pre-submission meeting and was conducted to Good Clinical Practice ('GCP') standards and ethical principles for medical research. An EFS study was defined by FDA as a pre-requisite for the first in class (De Novo) medical device with OTC classification.\n12 subjects were recruited into the study with 11 completing all elements: five pre-menopausal and six post-menopausal. After initial screening for suitability, subjects were formally diagnosed by using the FSFI instrument which is a fully validated self-completed questionnaire that has become the gold standard and most widely used measuring instrument in this scientific field1.\nWhen entering the study, the subjects were measured pre-treatment at a baseline after four sexual encounters using the FSFI and measured post-treatment after four weeks and a minimum of four sexual encounters. In addition, subjects recorded their experience after each post-treatment sexual encounter using the FSEP instrument, another validated and widely used questionnaire.\nAbout WSD4000\nWSD4000 is a topical treatment designed for sexual dysfunction in women. Currently, no regulatory approved topical treatment for sexual dysfunction in women is available over the counter. WSD4000 has the potential to be an effective, breakthrough treatment for the common symptoms associated with sexual dysfunction, such as impaired arousal, lubrication and desire.\nThe market for WSD4000\nAccording to published data, between 40% and 50% of women experience at least one symptom of sexual dysfunction2. Recently, the Company commissioned IPSOS to undertake market research in the US in 1,000 women, and this showed that around 60% have suffered from at least one symptom of sexual dysfunction in the last twelve months. In addition, only one in four women seek professional help and despite their efforts, many women continue to struggle with symptoms of sexual dysfunction\nwith f\new women (13%) experiencing an improvement in symptoms over time and 37% getting worse over time\n3\n.\nKen James, Executive Director and Head of R&D, commented:\n\"We are delighted with the results from the Early Feasibility Study which show clear and positive trends, demonstrating that the product can deliver a significant improvement in impaired sexual function in women. With our specialism in developing and bringing to market topically delivered gel formulations for improved sexual health, we believe we can successfully build on these results and provide a treatment for a condition that affects a significant number of women worldwide.\nWe look forward to updating the market over the coming months on the next steps for WSD4000, including results of the placebo and home user studies as a precursor to designing a Phase 3 clinical study, as well as preparation of product positioning, packaging and the launch strategy.\"\n1\nMeston et al, Scoring and Interpretation of the FSFI. What can be learnt from 20 years of use? J Sex Med 2020 Jan 17(1):17-25\n2\nSource: McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R etal. Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016 Feb;13(2):144-52\n3\nIpsos research carried out on behalf of Futura Medical in the USA amongst 1,003 women, 2024\nThe information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019.\nContacts:\nFutura Medical plc\nAlex Duggan\nChief Executive Officer\nAngela Hildreth\nFinance Director and COO\ninvestor.relations@futuramedical.com\n+44 (0)1483 685 670\nwww.futuramedical.com\nPanmure Liberum\nNominated Adviser\nand Broker\nEmma Earl, Will Goode, Mark Rogers (Corporate Finance)\n+44 (0)20 3100 2000\nTurner Pope Investments (TPI) Ltd - Broker\nGuy McDougall\n, Andrew Thacker\n+44 (0) 20 3657 0050\nAlma Strategic Communications\nRebecca Sanders-Hewett, Sam Modlin, Sarah Peters\n+44 (0)20 3405 0205\nfutura@almastrategic.com\nNotes to Editors:\nFutura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon\u00ae\u00a0and development products WSD4000 and Eroxon\u00ae\u00a0Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.\nSexual health issues are prevalent in both men and women.\nErectile Dysfunction (\"ED\")\nimpacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40. Around 60% of women experience at least one symptom of sexual dysfunction, and only one in four women seek professional help, and remain chronically underserved.\nEroxon\u00ae, Futura's clinically proven lead product, has been developed for the treatment of ED. The highly differentiated product, which is the only topical gel treatment for ED available over the counter and helps men get an erection in ten minutes, addresses significant unmet needs in the ED market. Eroxon\u00ae\u00a0has been nominated for a number of healthcare industry awards and has won two to-date.\nFutura has distribution partners in place in a number of major consumer markets including Haleon in the US, the largest market for ED in the world, and Cooper Consumer Health in Europe.\nThe WSD4000 is a prototype designed for the symptoms of impaired sexual response and function in women. There is currently no regulatory approved OTC treatment available for impaired sexual response and function in women. WSD4000 has the potential to be an effective, breakthrough treatment for the common symptoms associated with impaired sexual response and function, such as lack of desire, arousal and lubrication.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBBMMTMTJBTIF",
          "rns_number": "RNS Number : 4887O"
        },
        {
          "title": "Notification of major holdings",
          "announcement_date": "7th Jan 2026",
          "release_time": "4:34 pm",
          "source": "RNS",
          "content": "7 Jan 2026 16:34\nRNS Number : 0538O\nFutura Medical PLC\n07 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB0033278473\nIssuer Name\nFUTURA MEDICAL PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments; An event changing the breakdown of voting rights\n3. Details of person subject to the notification obligation\nName\nSpreadex LTD\nCity of registered office (if applicable)\nSt. Albans\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n06-Jan-2026\n6. Date on which Issuer notified\n07-Jan-2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n0.000000\n3.923200\n3.923200\n22806403\nPosition of previous notification (if applicable)\n0.000000\n4.436800\n4.436800\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB0033278473\n0\n0.000000\nSub Total 8.A\n0\n0.000000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nCFD/Spread Bet\n22806403\n3.923200\nSub Total 8.B1\n22806403\n3.923200%\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\nLawson Roberts01727 895145Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see\nwww.spreadex.com/financials\n.\n12. Date of Completion\n07-Jan-2026\n13. Place Of Completion\nUnited Kingdom\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUPUCWGUPQGQM",
          "rns_number": "RNS Number : 0538O"
        },
        {
          "title": "Total Voting Rights",
          "announcement_date": "31st Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "31 Dec 2025 07:00\nRNS Number : 1475N\nFutura Medical PLC\n31 December 2025\n31 December 2025\nFutura Medical plc\n(\"Futura\", \"the Group\" or the \"Company\")\nTotal Voting Rights\nFutura Medical plc\u00a0(AIM: FUM), the pharmaceutical company developing innovative sexual health products, announces that for the purposes of the FCA's Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 581,327,755 Ordinary Shares.\nSince the Company currently holds no shares in treasury, the total number of voting rights in the Company is 581,327,755 and this figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.\nContacts:\nFutura Medical plc\nAlex Duggan\nChief Executive Officer\nAngela Hildreth\nFinance Director and COO\ninvestor.relations@futuramedical.com\n+44 (0)1483 685 670\nwww.futuramedical.com\nPanmure Liberum\nNominated Adviser\nand Broker\nEmma Earl, Will Goode, Mark Rogers (Corporate Finance)\n+44 (0)20 3100 2000\nTurner Pope Investments (TPI) Ltd - Broker\nGuy McDougall\n, Andrew Thacker\n+44 (0) 20 3657 0050\nAlma Strategic Communications\nRebecca Sanders-Hewett, Sam Modlin, Emma Thompson\n+44 (0)20 3405 0205\nfutura@almastrategic.com\nNotes to Editors:\nFutura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon\u00ae\u00a0and development products WSD4000 and Eroxon\u00ae\u00a0Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.\nSexual health issues are prevalent in both men and women.\nErectile Dysfunction (\"ED\")\nimpacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40. Around 60% of women experience at least one symptom of sexual dysfunction, and only one in four women seek professional help, and remain chronically underserved.\nEroxon\u00ae, Futura's clinically proven lead product, has been developed for the treatment of ED. The highly differentiated product, which is the only topical gel treatment for ED available over the counter and helps men get an erection in ten minutes, addresses significant unmet needs in the ED market. Eroxon\u00ae\u00a0has been nominated for a number of healthcare industry awards and has won two to-date.\nFutura has distribution partners in place in a number of major consumer markets including Haleon in the US, the largest market for ED in the world, and Cooper Consumer Health in Europe.\nWSD4000 is a topical treatment designed for the symptoms of impaired sexual response and function in women. There is currently no regulatory approved OTC treatment available for impaired sexual response and function in women. WSD4000 has the potential to be an effective, breakthrough treatment for the common symptoms associated with impaired sexual response and function, such as lack of desire, arousal and lubrication.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVRFZMFZGGLGKZM",
          "rns_number": "RNS Number : 1475N"
        }
      ],
      "themes": [
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 425,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "UPTREND"
    },
    "volatility": {
      "atr_normalized": 6.02,
      "stddev_20d": 0.3466
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2026-01-12"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "INDUSTRIALS",
      "name": "Industrials",
      "icon": "\ud83c\udfed",
      "color": "#64748b",
      "crash_patterns": [
        "Order book decline or cancellations",
        "Margin compression (input costs)",
        "Cyclical demand weakness",
        "Project delays or overruns",
        "Working capital strain"
      ],
      "recovery_paths": [
        "Order book growth or new contracts",
        "Margin recovery (efficiency gains)",
        "Cyclical upturn (capex recovery)",
        "M&A consolidation",
        "Product innovation or new markets"
      ],
      "active_patterns": [
        "Project delays or overruns"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Order book value (forward revenue)",
        "Book-to-bill ratio",
        "Operating margin trends",
        "Working capital efficiency",
        "Capex cycles (customer industries)"
      ]
    },
    "panic_analysis": {
      "panic_score": 70,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 40,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 40/40 points"
      ],
      "facts_points": [],
      "verdict": "\ud83c\udfaf CONTRARIAN OPPORTUNITY - Fear dominates but facts support recovery potential"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 70/100",
        "color": "#f59e0b"
      },
      {
        "type": "CONFIRMED",
        "icon": "\u2705",
        "text": "Confirmed",
        "color": "#10b981"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 50",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Results of WSD4000 Early Feasibility Study",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Notification of major holdings",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Total Voting Rights",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c HOLD/WATCH - timing CONFIRMED",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "70/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "CONFIRMED",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "50/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "60/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "1 active",
          "pass": true,
          "icon": "\ud83c\udfed"
        }
      ],
      "pass_rate": "5/5"
    },
    "contrarian_panic": {
      "total_score": 60,
      "band": "\ud83d\udfe0 HIGH COMPRESSION (Top 15% - STRONG OPPORTUNITY)",
      "components": {
        "compression": {
          "score": 35,
          "max": 40,
          "signals_30d": 11,
          "signals_60d": 13,
          "signals_90d": 21,
          "signals_per_week": 1.62,
          "total_signals": 25,
          "rsi_extreme_count": 12,
          "rsi_ultra_count": 1,
          "escalation_count": 2,
          "density_score": 15,
          "rsi_score": 10,
          "escalation_score": 7,
          "description": "1.6 signals/week | 12 RSI<20 | 2 escalations | \ud83d\udd25 EXTREME COMPRESSION"
        },
        "intensification": {
          "score": 8,
          "max": 20,
          "recent_types": [
            "ENHANCED EXTREME CRASH-ACCUM COMBO",
            "ENHANCED CRASH CRASH-ACCUM COMBO",
            "ENHANCED CRASH CRASH-ACCUM COMBO"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 5,
          "pattern": "AT EXTREME LEVEL"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.47,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 4,
          "max": 15,
          "best_historical_rally": 80.2,
          "avg_rally": 30.9,
          "signal_count": 25,
          "description": "Baseline mover (80%)"
        },
        "accumulation": {
          "score": 8,
          "max": 10,
          "has_accumulation": true,
          "bars_since_accum": 1,
          "description": "Accum 1 bars ago"
        }
      },
      "ticker": "FUM.L",
      "signal_date": "2025-12-10",
      "total_signals_history": 25
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +11 (AI_Technical_Score=9.0/20)",
      "Drawdown reversion potential: +19 (Drawdown_Pct=96.8%)",
      "Volume confirmation: +10 (Relative_Volume=2.5)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +5 (best_rally_pct=44%)"
    ],
    "technical_score": {
      "points": 11,
      "ai_score": 9.0,
      "reason": "AI Technical Score 9.0/20 translates to 11/25 points"
    },
    "drawdown_score": {
      "points": 19,
      "drawdown_pct": 96.82,
      "reason": "Drawdown of 96.8% gives 19/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.47,
      "reason": "Relative volume 2.47x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 5,
      "best_rally_pct": 43.52,
      "reason": "Best rally of 44% gives 5/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": []
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Active trade",
      "action": "HOLD/WATCH",
      "sizing": "1-3% position based on conviction",
      "risk": "Stop below recent support / invalidation level",
      "profit_taking": "Scale out into strength: 25% @ +15%, 50% @ +50%, trail runner"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "CONFIRMED",
    "run_multiple": 0.35,
    "current_run_pct": 15.05,
    "avg_historical_run_pct": 43.52
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows CONFIRMED timing with 50/100 APEX score. Historical data shows 1 rallies averaging 44% upside. Current position: +15.1%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Limited upside case without catalysts"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Momentum confirmed. This is the trade zone if thesis holds.",
    "confidence_explained": "Confidence 60/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}